Based on data from this study, we estimate that 34% of de novo damaging mutations seen in OCD carry risk and that 335 genes confer risk in 22% of patients (Figure 2B). Given our OCD sample size, the 95% confidence intervals around these contribution estimates are wide and need refinement by continued sequencing of OCD trios.
